0001415889-23-013116.txt : 20230908 0001415889-23-013116.hdr.sgml : 20230908 20230908160243 ACCESSION NUMBER: 0001415889-23-013116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230906 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Young Alethia CENTRAL INDEX KEY: 0001918147 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 231245277 MAIL ADDRESS: STREET 1: C/O GRAPHITE BIO, INC. STREET 2: 201 HASKINS WAY, SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-09082023_080934.xml X0508 4 2023-09-06 0001070081 PTC THERAPEUTICS, INC. PTCT 0001918147 Young Alethia C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 true false false false 0 Common Stock 2023-09-06 4 M 0 7000 27.85 A 16067 D Common Stock 2023-09-06 4 S 0 7000 39.90 D 9067 D Common Stock 2023-09-06 4 M 0 4666 27.85 A 13733 D Common Stock 2023-09-06 4 S 0 4666 39.7926 D 9067 D Stock Option (Right to Buy) 27.85 2023-09-06 4 M 0 7000 27.85 D 2032-06-08 Common Stock 7000 0 D Stock Option (Right to Buy) 27.85 2023-09-06 4 M 0 4666 27.85 D 2032-06-08 Common Stock 4666 7334 D Stock Option (Right to Buy) 39.42 2033-01-04 Common Stock 10000 10000 D This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $39.77 to $39.88 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Currently exercisable. This option was granted on June 9, 2022 and vests over thirty-six approximately equal monthly installments, commencing on July 8, 2022 This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2023-09-08